| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| furosemid 80 mg/8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| furosemid 80 mg/8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| filgrastim (som pegfilgrastim) 6 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| filgrastim (som pegfilgrastim) 6 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 60 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 60 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 180 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 200 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fulvestrant 250 mg/5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fulvestrant 250 mg/5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| jod (som jotrolan) 2,4 g/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 450 mg/50 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 250 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gallamintrietjodid 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gallamintrietjodid 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 120 mg/3 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| bovint insulin (som bovint lösligt protaminzinkinsulin) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| somatropin (epr) 5 mg/1,5 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| somatropin (epr) 5 mg/1,5 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumklorid 45 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 50 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| pentagastrin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| insulin från gris (som porcint lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 500 mg/50 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dinatriumklodronat 300 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dinatriumklodronat 300 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metoxipolyetylenglykol-epoetin beta 75 mikrogram/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| ganirelix 250 mikrogram/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 5 g/200ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| glatirameracetat 20 mg/ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| glatirameracetat 20 mg/ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
| felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| felypressin 0,06 enheter/2 ml + prilokainhydroklorid 60 mg/2 ml, injektionsvätska, lösning, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
| pentazocin (som pentazocinlaktat) 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| pentazocin (som pentazocinlaktat) 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| xylometazolinhydroklorid 500 mikrogram/milliliter, näsdroppar, lösning |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumglycerofosfat 4,32 g/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metylnaltrexonbromid 12 mg/0,6 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 20 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| pentazocin (som pentazocinlaktat) 60 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| pentazocin (som pentazocinlaktat) 60 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som kristallinsk human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 1 g/50 ml, injektionsvätska, emulsion, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 1 g/50 ml, injektionsvätska, emulsion, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumhyaluronat 8,5 mg/0,85 ml, intraokulär injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumhyaluronat 8,5 mg/0,85 ml, intraokulär injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 40 mg/ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 40 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 40 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 15 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 15 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som blandad human zinkinsulinsuspension) 1 000 enheter/10 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som humant isofaninsulin) 300 enheter/3 ml, injektionsvätska, suspension, cylinderampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som humant isofaninsulin) 300 enheter/3 ml, injektionsvätska, suspension, cylinderampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumhyaluronat 5,5 mg/0,55 ml, intraokulär injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumhyaluronat 5,5 mg/0,55 ml, intraokulär injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metylprednisolonacetat 80 mg/2 ml, injektionsvätska, suspension, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fenol 1,25 g/25 ml, olja för injektion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenol 1,25 g/25 ml, olja för injektion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumnitrit 300 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natriumnitrit 300 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 80 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| foskarnetnatrium 6 g/250 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| foskarnetnatrium 6 g/250 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 30 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fenobarbitalnatrium 30 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| irinotekanhydrokloridtrihydrat 40 mg/2 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metoklopramidhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metoklopramidhydroklorid 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fenoxibensaminhydroklorid 100 mg/2 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fenoxibensaminhydroklorid 100 mg/2 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| irinotekanhydrokloridtrihydrat 100 mg/5 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| nitroglycerin 10 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| nitroglycerin 10 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |